Evidence map›Paper›PMID 39586927›Full record

ArticleDigestive diseases and sciences2025

Trends and Symptoms Among Increasing Proportion of African Americans with Early-Onset Colorectal Cancer over a 60-Year Period.

Hassan Brim, Challa Suryanarayana Reddy, Lakshmi Chirumamilla, Gholamreza Oskrochi, Mrinalini Deverapalli, Rumaisa Rashid, Mudasir Rashid, Vaisakh Nair, Nicole Morrison, Danae Byer and 26 more

Abstract read
In one paragraph

Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Monitoring of Colorectal Cancer Screening Adherence Among African American Patients of North Florida Community Health Centers.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Hassan BrimDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Challa Suryanarayana ReddyDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Lakshmi ChirumamillaDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Gholamreza OskrochiCollege of Engineering and Technology, American University of the Middle East, Egaila, Kuwait.
Mrinalini DeverapalliDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Rumaisa RashidDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Mudasir RashidDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Vaisakh NairDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Nicole MorrisonDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Danae ByerDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Trae ThompsonDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Belal YasinDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
David JohnsonDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Alicia SnowdenDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Priscilla MammenDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Gabriel CarterDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Victor JollyDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Rasheed ThompsonDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Riad AbdulmoniemDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Nima KarodehDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Yafiet GojelaDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Ali AhmedDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Sabtain SaroyaDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Trinity GibbsDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Dideolu DawoduDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Nader ShayeghDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Ali H AhmedDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Iman ZahediDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Farshad AduliDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Angesom KibreabDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Adeyinka O LaiyemoDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Babak ShokraniDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Rabia ZafarDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
Christine NembhardDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.
John M CarethersDepartment of Medicine, Moores Cancer Center, Wertheim School of Public Health and Human Longevity, University of California San Diego, San Diego, CA, USA.
Hassan AshktorabDepartment of Medicine, Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA. hashktorab@Howard.edu.

Funding

Sleep Disorders in Adults with Sickle Cell Disease: Frequency, Associations with Cardiovascular and Pain Indicators, and Responses to TreatmentU54MD007597 · NIMHD · HOWARD UNIVERSITY · PI BYRON D. FORD · 2019 to 2026
$37.7M
Inactivation of MSH3 in Colorectal Cancer and RaceR01CA258519 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ASHKTORAB, HASSAN, CARETHERS, JOHN M · 2021 to 2025
$2.9M
NCI NIH HHS R01 CA258519NCI NIH HHS RO1 CA258519NIH HHS U54MD007597
6 · The paper itself

Abstract

backgroundThe proportion of early onset colorectal cancer (EOCRC) is alarming in adults, including in African Americans (AA).

aimTo investigate differences between EOCRC compared to late-onset colorectal cancer (LOCRC) among AA patients.

methodsThis retrospective study reviewed demographic, clinical presentations, colonoscopy, and pathology reports of patients at Howard University Hospital from 1959 to 2023. The study included 176 EOCRC cases (< 45 years) and 2034 LOCRC cases (> 45 years).

resultsBoth EOCRC and LOCRC groups were predominantly AA (> 80%) with slightly more females (53%) than males. The mean age was 38 years for EOCRC and 66 years for LOCRC cases. EOCRC cases increased as a proportion of total detected CRC cases since 2010 (over 13%) after several decades of just above 6%. Family history of CRC in first degree relatives was higher among EOCRC (15.5% vs.3.4% in LOCRC patients, p < 0.01). Symptoms at presentation were prevalent in both EOCRC (93.8%) and LOCRC (92.6%). EOCRC patients exhibited higher incidence of abdominal pain (23.3% vs. 17.2%, p = 0.05) and changes in bowel habits (24.4% vs. 14%, p < 0.01) compared to LOCRC patients. Other symptoms such as melena, hematochezia, and weight loss were less prevalent in EOCRC patients. Comorbidities like hypertension (HTN), diabetes mellitus (DM), and inflammatory bowel disease (IBD) were less frequent among EOCRC patients. EOCRC was primarily observed in the sigmoid and rectosigmoid regions (p = 0.02). Metastasis at index colonoscopy was more prevalent with EOCRC compared to LOCRC (p = 0.04), with a higher proportion of patients at stage 3 cancer (p < 0.05). Significant differences were noted in the timeline for undergoing surgery after the diagnosis of colorectal cancer, with EOCRC patients taking longer than LOCRC patients (p = 0.03).

conclusionPresentation of EOCRC over LOCRC increased proportionally in our cohort since 2010 and is associated with family history, and symptoms such as abdominal pain and change in bowel habits. Likely because of age at presentation, there are less comorbidities among EOCRC patients who predominantly present in the outpatient setting, and more likely diagnosed with advanced stage lesions that are predominantly sigmoid or rectosigmoid. These findings are similar to observations seen in the general population with EOCRC, albeit African American patients have commonly had earlier age presentation of CRC than White American patients.

Indexed as

Black or African AmericanColorectal NeoplasmsAdultAgedAge of OnsetColonoscopyFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesAfrican AmericansColorectal cancerEarly-onsetLate-onset

Identifiers

PMID39586927
PMCPMC12129110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.